hypericin has been researched along with Triple Negative Breast Neoplasms in 1 studies
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Souza, MVF | 1 |
| Shinobu-Mesquita, CS | 1 |
| Meirelles, LEF | 1 |
| Mari, NL | 1 |
| César, GB | 1 |
| Gonçalves, RS | 1 |
| Caetano, W | 1 |
| Damke, E | 1 |
| Silva, VR | 1 |
| Damke, GM | 1 |
| Consolaro, MEL | 1 |
1 other study available for hypericin and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Effects of hypericin encapsulated on Pluronic F127 photodynamic therapy against triple negative breast cancer.
Topics: Anthracenes; Humans; Perylene; Photochemotherapy; Poloxamer; Triple Negative Breast Neoplasms | 2022 |